CD8A and neoplasm: An up-regulation of tetramer+ CD8+ T cells was also observed in the lymph nodes and the TME, signifying a systemic activation of anti-tumor immunity upon MHC-I‒E6‒mEry administration (Fig. 3g; Supplementary Fig. S6c, d).